Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program

Gastroenterology

Volumn 147, Issue 6, 2014, Pages 1317-1326

  Chiang, Tsung Hsien ^a,b   Chuang, Shu Lin ^c   Chen, Sam Li Sheng ^d   Chiu, Han Mo ^a,c   Yen, Amy Ming Fang ^d   Chiu, Sherry Yueh Hsia ^e   Fann, Jean Ching Yuan ^f   Chou, Chu Kuang ^a,g   Lee, Yi Chia ^a,b,c   Wu, Ming Shiang ^a   Chen, Hsiu Hsi ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e CHANG GUNG UNIVERSITY   (Taiwan)

^f KAINAN UNIVERSITY   (Taiwan)

^g CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Colorectal Cancer; Interval Cancer; Population Screening; Screening Test Sensitivity

Indexed keywords

HEMOGLOBIN;

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; COLONOSCOPY; COLORECTAL CANCER; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENVIRONMENTAL TEMPERATURE; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; HUMAN; IMMUNOASSAY ANALYZER; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PREDICTIVE VALUE; RISK FACTOR; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SIGMOIDOSCOPY; ADENOMA; BIOLOGICAL MODEL; CHEMISTRY; COLORECTAL NEOPLASMS; FECES; INCIDENCE; JAPAN; MASS SCREENING; MIDDLE AGED; MORTALITY; OCCULT BLOOD; PROCEDURES; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA;

ADENOMA; AGED; COLORECTAL NEOPLASMS; FECES; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOCHEMISTRY; INCIDENCE; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; MODELS, BIOLOGICAL; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; REFERRAL AND CONSULTATION; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84913532123     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.08.043     Document Type: Article

References (41)

1. A. Shaukat, S.J. Mongin, and M.S. Geisser Long-term mortality after screening for colorectal cancer N Engl J Med 369 2013 1106 1114
2. T.F. Imperiale Noninvasive screening tests for colorectal cancer Dig Dis 30 Suppl 2 2012 16 26
3. T.H. Chiang, Y.C. Lee, and C.H. Tu Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract CMAJ 183 2011 1474 1481
4. J.K. Lee, E.G. Liles, and S. Bent Accuracy of fecal immunochemical tests for colorectal cancer Ann Intern Med 160 2014 171 181
5. Evolution of Cancer Screening in Taiwan. Health Promotion Administration, Ministry of Health and Welfare, Taiwan (R.O.C.). Available at: http://www.hpa.gov.tw/English/index.aspx. Accessed January 8, 2014.
6. C.G. Fraser, J.E. Allison, and S.P. Halloran A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin J Natl Cancer Inst 104 2012 810 814
7. V.S. Benson, W.S. Atkin, and J. Green International Colorectal Cancer Screening Network. Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network Int J Cancer 130 2012 2961 2973
8. Bosman FT, Carneiro F, Hruban RH, et al, eds. WHO Classification of Tumours of the Digestive System. IARC: Lyon, 2010.
9. C.J. Chiang, Y.C. Chen, and C.J. Chen Taiwan Cancer Registry Task Force. Cancer trends in Taiwan Jpn J Clin Oncol 40 2010 897 904
10. N.E. Day Estimating the sensitivity of a screening test J Epidemiol Community Health 39 1985 364 366
11. F. Bray, J.S. Ren, and E. Masuyer Global estimates of cancer prevalence for 27 sites in the adult population in 2008 Int J Cancer 132 2013 1133 1145
12. H. Brenner, M. Hoffmeister, and C. Stegmaier Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies Gut 56 2007 1585 1589
13. T.J. Cheng, F.C. Lee, and S.J. Lin Improper cause-of-death statements by specialty of certifying physician: a cross-sectional study in two medical centres in Taiwan BMJ Open 2 2012 e001229
14. S.W. Duffy, J. Cuzick, and L. Tabar Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes J R Stat Soc Ser C (Appl Stat) 51 2002 235 243
15. R.J. Steele, P. McClements, and C. Watling Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site Gut 61 2012 576 581
16. S.B. Edge, D.R. Byrd, and M.A. Carducci American Joint Committee on Cancer (AJCC) Cancer Staging Manual 7th ed. 2009 Springer New York
17. M. Hakama, A. Auvinen, and N.E. Day Sensitivity in cancer screening J Med Screen 14 2007 174 177
18. M. Zappa, G. Castiglione, and E. Paci Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience Int J Cancer 92 2001 151 154
19. G. Castiglione, C.B. Visioli, and S. Ciatto Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme Br J Cancer 96 2007 1750 1754
20. M. Zorzi, C. Fedato, and G. Grazzini High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy Gut 60 2011 944 949
21. C. Campari, R. Sassatelli, and L. Paterlini Test and programme sensitivities of screening for colorectal cancer in Reggio Emilia Epidemiol Prev 35 2011 118 124 [Article in Italian]
22. L.G. van Rossum, A.F. van Rijn, and R.J. Laheij Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population Gastroenterology 135 2008 82 90
23. L. Hol, M.E. van Leerdam, and M. van Ballegooijen Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy Gut 59 2010 62 68
24. G.D. Launoy, H.J. Bertrand, and C. Berchi Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population Int J Cancer 115 2005 493 496
25. L. Guittet, V. Bouvier, and N. Mariotte Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population Gut 56 2007 210 214
26. J. Faivre, V. Dancourt, and B. Denis Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer Eur J Cancer 48 2012 2969 2976
27. T. Raginel, J. Puvinel, and O. Ferrand A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening Gastroenterology 144 2013 918 925
28. E. Quintero, A. Castells, L. Bujanda COLONPREV Study Investigators Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening N Engl J Med 366 2012 697 706
29. M.B. Zubero, E. Arana-Arri, and J.I. Pijoan Population-based colorectal cancer screening: comparison of two fecal occult blood test Front Pharmacol 4 2014 175
30. D. Major, H. Bryant, and M. Delaney Colorectal cancer screening in Canada: results from the first round of screening for five provincial programs Curr Oncol 20 2013 252 257
31. L.S. Chen, C.S. Liao, and S.H. Chang Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16) J Med Screen 14 2007 191 199
32. L. Guittet, L. Bailly, and V. Bouvier Indirect comparison of two quantitative immunochemical faecal occult blood tests in a population with average colorectal cancer risk J Med Screen 18 2011 76 81
33. H. Brenner, U. Haug, and S. Hundt Sex differences in performance of fecal occult blood testing Am J Gastroenterol 105 2010 2457 2464
34. G.P. Young, and D.J.B. St John Selecting an occult blood test for use as a screening tool for large bowel cancer Front Gastrointest Res 18 1991 135 156
35. T. Morikawa, J. Kato, and Y. Yamaji A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population Gastroenterology 129 2005 422 428
36. Z. Levi, P. Rozen, and R. Hazazi A quantitative immunochemical fecal occult blood test for colorectal neoplasia Ann Intern Med 146 2007 244 255
37. H.M. Chiu, Y.C. Lee, and C.H. Tu Association between early stage colon neoplasms and false-negative results from the fecal immunochemical test Clin Gastroenterol Hepatol 11 2013 832 838
38. J.E. Allison, C.G. Fraser, and S.P. Halloran Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT) Gut Liver 8 2014 117 130
39. S. Rapi, T. Rubeca, and C.G. Fraser How to improve the performances of Fecal Immunological Tests (FIT): need for standardization of the sampling and pre-analytical phases and revision of the procedures for comparison of methods Int J Biol Markers 2014 May 22 Epub ahead of print
40. G. Grazzini, L. Ventura, and M. Zappa Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district Gut 59 2010 1511 1515
41. T. Rubeca, B. Peruzzi, and M. Confortini Overall evaluation of an immunological latex agglutination system for fecal occult blood testing in the colorectal cancer screening program of Florence Int J Biol Markers 27 2012 e195 e3202